1. Rationale for use of Tdap booster vaccines for adolescent immunization: Overview of efficacy, safety, and clinical use;Hitchcock;Clin Pediatr,2006
2. Summary of notifiable diseases—United States;McNabb;Morbid Mortal Wkly Rep,2005
3. Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP);Broder;MMWR Recomm Rep,2006
4. Food and Drug Administration. Product approval information—licensing action, package insert: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed ADACEL™. sanofi pasteur. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005. Available at http://www.fda.gov/cber/products/adacel.htm.
5. Food and Drug Administration. Product approval information—licensing action, package insert: BOOSTRIX. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed BOOSTRIX. GlaxoSmithKline. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2005. Available at http://www.fda.gov/cber/products/boostrix.htm.